Innate immunity and apoptosis in IBD.
Lichtenberger
G Scott
GS
Yale University School of Medicine, Section of Digestive Diseases, New Haven, Connecticut 06520, USA.
Flavell
Richard A
RA
Alexopoulou
Lena
L
D048868:Adaptor Proteins, Signal Transducing; D017209:Apoptosis / Q000276:immunology*; D002352:Carrier Proteins / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D018928:Immunity, Mucosal; D015212:Inflammatory Bowel Diseases / Q000276:immunology*; D007413:Intestinal Mucosa / Q000276:immunology; D047908:Intracellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins / Q000276:immunology / Q000378:metabolism; D053474:Nod1 Signaling Adaptor Protein; D053473:Nod2 Signaling Adaptor Protein; D011956:Receptors, Cell Surface / Q000276:immunology / Q000378:metabolism; D051193:Toll-Like Receptors
D048868:Adaptor Proteins, Signal Transducing; D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D008562:Membrane Glycoproteins; C119067:NOD1 protein, human; C429018:NOD2 protein, human; D053474:Nod1 Signaling Adaptor Protein; D053473:Nod2 Signaling Adaptor Protein; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors